1. Riggs CE, Bachur NR (1983) Clinical pharmacokinetics of anthracycline antibiotics. In: Ames MM, Powis G, Kovach JS (eds) Pharmacokinetics of anticancer agents in humans. Elsevier, Amsterdam
2. Robert J, Vrignaud P, Eghbali H, Nguyen-Ngoc T, Hoerni B (1985) Tentative dose monitoring of doxorubicin in lymphoma patients. Med Oncol Tumor Pharmacother 2: 225?259
3. O'Bryan RM, Baker LH, Gottlieb JE et al. (1977) Dose-response evaluation of adriamycin in human neoplasia. Cancer 39: 1940?1948
4. Bui NB, Chauvergne J, Hocke C, Durand M, Brunet R, Coindre JM (1985) Analysis of a series of sixty soft-tissue sarcomas in adults treated with a cyclophosphamide ? vincristine ? adriamycin ? dacarbazine (CYVADIC) combination. Cancer Chemother Pharmacol 15: 82?85
5. Robert J, Iliadis A, Hoerni B, Cano JP, Durand M, Lagarde C (1982) Pharmacokinetics of doxorubicin in patients with breast cancer. Correlation between pharmacokinetic parameters and clinical short-term response. Eur J Cancer Clin Oncol 18: 739?745